Ati Physical Therapy Stock News

ATI Physical Therapy (ATIP) +16%. Cardiovascular Systems (CSII) +14%. Acutus Medical (AFIB) -9%. GeoVax Labs (GOVX) -9%.

Jefferies points out: Relative to the competition, ATI stock looks awfully cheap.

Jefferies  upgraded ATI Physical Therapy Inc (NYSE:ATIP) stock to Buy from Hold with a price target of $5, up from $3.50. The increased price target represents about 65% upside to the January 13 cl

Which penny stocks are you watching right now? The post Check These 3 Penny Stocks Out For Your End of Week List appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Benzinga's weekly Stock Wars matches up two leaders in a major industry sector with the goal of determining which company is the better investment. This week, the duel is between a pair of companies i

NEW YORK, Dec. 23, 2021 (GLOBE NEWSWIRE) -- ATI Physical Therapy, Inc. (NYSE: ATIP)

ATI Physical Therapy Inc. (NYSE:ATIP) concluded the trading at $3.02 on Wednesday, December 22 with a fall of -2.89% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day was $3.11 with its price kept floating in the range of $2.985 and $3.15 on ATI Physical Therapy Inc. (ATIP) Is Worth Investing In Read More »

ATI Physical Therapy, Inc. (NYSE:ATIP) gapped down prior to trading on Monday . The stock had previously closed at $3.25, but opened at $3.05. ATI Physical Therapy shares last traded at $3.13, with a volume of 24,786 shares. A number of equities analysts recently weighed in on the stock. Zacks Investment Research raised shares of []

Wall Street brokerages predict that ATI Physical Therapy, Inc. (NYSE:ATIP) will announce $156.27 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for ATI Physical Therapys earnings, with the lowest sales estimate coming in at $155.20 million and the highest estimate coming in at $157.34 million. The []

Equities analysts forecast that ATI Physical Therapy, Inc. (NYSE:ATIP) will post earnings of ($0.08) per share for the current fiscal quarter, according to Zacks Investment Research. Two analysts have issued estimates for ATI Physical Therapys earnings. The business is expected to report its next earnings report on Wednesday, February 16th. According to Zacks, analysts expect []

Zacks Investment Research upgraded shares of ATI Physical Therapy (NYSE:ATIP) from a hold rating to a buy rating in a report released on Friday, Zacks.com reports. Zacks Investment Research currently has $3.50 target price on the stock. According to Zacks, ATI Physical Therapy Inc. is a portfolio company of Advent International as well as provider []

Zacks Investment Research upgraded shares of ATI Physical Therapy (NYSE:ATIP) from a hold rating to a buy rating in a research note issued to investors on Tuesday, Zacks.com reports. The brokerage currently has $3.50 price target on the stock. According to Zacks, ATI Physical Therapy Inc. is a portfolio company of Advent International as well []

NEW YORK--(BUSINESS WIRE)-- #ATI--Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against ATI Physical Therapy, Inc. (NYSE: ATIP) on behalf of long-term stockholders following a class action complaint that was filed against ATI on August 16, 2021. Our investigation concerns whether the board of directors of ATI have breached their fiduciary duties to the company. The complaint filed in this class action alleges that throughout the

Equities research analysts expect ATI Physical Therapy, Inc. (NYSE:ATIP) to announce $156.27 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for ATI Physical Therapys earnings, with estimates ranging from $155.20 million to $157.34 million. The firm is scheduled to announce its next quarterly earnings results on Wednesday, February []

ATI Physical Therapy, Inc. (NYSE:ATIP) Chairman John L. Larsen purchased 10,000 shares of the businesss stock in a transaction that occurred on Tuesday, November 30th. The stock was purchased at an average price of $3.63 per share, for a total transaction of $36,300.00. The acquisition was disclosed in a filing with the Securities & Exchange []